Cristian Barrera
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Cristian Barrera has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Anant Madabhushi
Department of Biomedical Engineering, Emory University, Atlanta, GA
3 shared publications Cheng Lu
Department of Radiology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Guangzhou, China
2 shared publications- Kaustav Bera
Department of Radiology, University Hospitals Cleveland Medical Center, Cleveland, OH
2 shared publications - Xiangxue Wang
School of Artificial Intelligence, Nanjing University of Information Science and Technology, Nanjing, China
2 shared publications - Abdullah Osme
Department of Anatomic Pathology, University of Alabama at Birmingham, Birmingham, AL 35294, USA
1 shared publication - Afshin Dowlati
University Hospitals Seidman Cancer Center and Case Western Reserve University, Cleveland, OH
1 shared publication
Latest Publications
- Open Access
- 15 November 2025
- Published by Elsevier in Cancer Letters
- Vol. 636, 218134
A deep learning framework to iDentify prOgnostically releVant cancEr Regions (DOVER) within whole slide histopathology images
- 15 November 2025
- Published by Elsevier in Cancer Letters
- Vol. 636, 218134
Open AccessA deep learning framework to iDentify prOgnostically releVant cancEr Regions (DOVER) within whole slide histopathology images
- 3 June 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (22) , eabn3966
Spatial interplay patterns of cancer nuclei and tumor-infiltrating lymphocytes (TILs) predict clinical benefit for immune checkpoint inhibitors
Immune checkpoint inhibitors (ICIs) show prominent clinical activity across multiple advanced tumors. However, less than half of patients respond even after molecule-based selection. Thus, improved biomarkers are required. In this study, we use an image analysis to capture morphologic attributes relating to the spatial interaction and architecture of tumor cells and tumor-infiltrating lymphocytes (TILs) from digitized H&E images. We evaluate the association of image features with progression-free (PFS) and overall survival in non–small cell lung cancer (NSCLC) ( N = 187) and gynecological cancer ( N = 39) patients treated with ICIs. We demonstrated that the classifier trained with NSCLC alone was associated with PFS in independent NSCLC cohorts and also in gynecological cancer. The classifier was also associated with clinical outcome independent of clinical factors. Moreover, the classifier was associated with PFS even with low PD-L1 expression. These findings suggest that image analysis can be used to predict clinical end points in patients receiving ICI.
- 3 June 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (22) , eabn3966
Spatial interplay patterns of cancer nuclei and tumor-infiltrating lymphocytes (TILs) predict clinical benefit for immune checkpoint inhibitors
Immune checkpoint inhibitors (ICIs) show prominent clinical activity across multiple advanced tumors. However, less than half of patients respond even after molecule-based selection. Thus, improved biomarkers are required. In this study, we use an image analysis to capture morphologic attributes relating to the spatial interaction and architecture of tumor cells and tumor-infiltrating lymphocytes (TILs) from digitized H&E images. We evaluate the association of image features with progression-free (PFS) and overall survival in non–small cell lung cancer (NSCLC) ( N = 187) and gynecological cancer ( N = 39) patients treated with ICIs. We demonstrated that the classifier trained with NSCLC alone was associated with PFS in independent NSCLC cohorts and also in gynecological cancer. The classifier was also associated with clinical outcome independent of clinical factors. Moreover, the classifier was associated with PFS even with low PD-L1 expression. These findings suggest that image analysis can be used to predict clinical end points in patients receiving ICI.
- 1 March 2021
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 16 (3) , S560
P68.02 Computer Extracted Morphology Features of Tumor Nuclei Predict Response to Chemotherapy and Prognostic of OS in Small Cell Lung Cancer
- 1 March 2021
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 16 (3) , S560
P68.02 Computer Extracted Morphology Features of Tumor Nuclei Predict Response to Chemotherapy and Prognostic of OS in Small Cell Lung Cancer